Barry Schechter

Barry Schechter

Chief Tech/Sci/R&D Officer chez AmnioChor, Inc.

Fortune : 10 500 $ au 31/03/2024

60 ans
Consumer Services
Health Services
Health Technology

Profil

Barry Schechter is the founder of Pediavision, Inc. He is currently the Director-Cornea & External Disease Department at Florida Eye Microsurgical Institute, Inc. since 2005.
He is also the Medical Director at AmnioChor, Inc. His former position includes being an Independent Director at Innovation Pharmaceuticals, Inc. from 2014 to 2024.
Dr. Schechter's education includes an undergraduate degree from Brooklyn College and City University of New York, as well as a doctorate from State University of New York at Downstate Medical Center.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
28/09/2023 750 000 ( 0,15% ) 10 500 $ 31/03/2024

Postes actifs de Barry Schechter

SociétésPosteDébut
Corporate Officer/Principal 01/01/2005
Chief Tech/Sci/R&D Officer -
Tous les postes actifs de Barry Schechter

Anciens postes connus de Barry Schechter

SociétésPosteFin
INNOVATION PHARMACEUTICALS INC. Director/Board Member 31/01/2024
Pediavision, Inc. Chief Executive Officer -
Voir l'expérience en détail de Barry Schechter

Formation de Barry Schechter

Brooklyn College Undergraduate Degree
City University of New York Undergraduate Degree
State University of New York at Downstate Medical Center Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Barry Schechter

Relations

13

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
INNOVATION PHARMACEUTICALS INC.

Health Technology

Entreprise privées3

Health Services

Pediavision, Inc.

Health Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Barry Schechter